Agnès Vitry

4.2k total citations · 1 hit paper
106 papers, 2.9k citations indexed

About

Agnès Vitry is a scholar working on Economics and Econometrics, Epidemiology and Pharmacology. According to data from OpenAlex, Agnès Vitry has authored 106 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Economics and Econometrics, 24 papers in Epidemiology and 22 papers in Pharmacology. Recurrent topics in Agnès Vitry's work include Health Systems, Economic Evaluations, Quality of Life (31 papers), Pharmaceutical Economics and Policy (31 papers) and Chronic Disease Management Strategies (23 papers). Agnès Vitry is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (31 papers), Pharmaceutical Economics and Policy (31 papers) and Chronic Disease Management Strategies (23 papers). Agnès Vitry collaborates with scholars based in Australia, Malaysia and Canada. Agnès Vitry's co-authors include Elizabeth E. Roughead, Gillian E. Caughey, Andrew L. Gilbert, Noordin Othman, Sepehr Shakib, Joel Lexchin, Huah Shin Ng, Peter Mansfield, Geoffrey Spurling and Jenny Doust and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Agnès Vitry

100 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review

2010 345 citations Joel Lexchin, Agnès Vitry et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Agnès Vitry Australia	29	1.0k	654	539	500	484	106	2.9k
Dima M. Qato United States	26	597 0.6×	855 1.3×	244 0.5×	412 0.8×	573 1.2×	89	3.3k
Rachel Elliott United Kingdom	35	925 0.9×	1.0k 1.6×	225 0.4×	356 0.7×	1000 2.1×	163	4.5k
Glen T. Schumock United States	36	1.2k 1.2×	1.3k 2.0×	262 0.5×	348 0.7×	485 1.0×	175	4.9k
Hisham Aljadhey Saudi Arabia	31	579 0.6×	1.0k 1.6×	267 0.5×	553 1.1×	304 0.6×	120	3.1k
Ingrid Sketris Canada	29	636 0.6×	1.1k 1.7×	243 0.5×	306 0.6×	568 1.2×	158	3.6k
Becky A. Briesacher United States	34	1.4k 1.4×	1.3k 1.9×	178 0.3×	269 0.5×	966 2.0×	123	4.2k
T Walley United Kingdom	31	761 0.7×	258 0.4×	247 0.5×	229 0.5×	569 1.2×	82	3.0k
Mariam Molokhia United Kingdom	30	325 0.3×	413 0.6×	729 1.4×	733 1.5×	354 0.7×	89	3.8k
Abraham G. Hartzema United States	37	534 0.5×	303 0.5×	247 0.5×	680 1.4×	334 0.7×	113	4.4k
Andreas Lundh Denmark	21	695 0.7×	308 0.5×	804 1.5×	272 0.5×	394 0.8×	54	3.0k

Countries citing papers authored by Agnès Vitry

Since Specialization

Citations

This map shows the geographic impact of Agnès Vitry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Vitry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Vitry more than expected).

Fields of papers citing papers by Agnès Vitry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Vitry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Vitry. The network helps show where Agnès Vitry may publish in the future.

Co-authorship network of co-authors of Agnès Vitry

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Vitry. A scholar is included among the top collaborators of Agnès Vitry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Vitry. Agnès Vitry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Modi, Natansh D., Ahmad Y. Abuhelwa, Nicole M. Kuderer, et al.. (2025). Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer. Cancer Medicine. 14(21). e71320–e71320.

Menz, Bradley D., Natansh D. Modi, Ahmad Y. Abuhelwa, et al.. (2025). Patient‐reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials. International Journal of Cancer. 157(10). 2135–2145.

Vitry, Agnès, et al.. (2024). Evidence of clinical benefit of cancer medicines considered for funding in Australia. International Journal of Technology Assessment in Health Care. 40(1). e55–e55.

Menz, Bradley D., Nicole M. Kuderer, Stephen Bacchi, et al.. (2024). Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis. BMJ. 384. e078538–e078538. 43 indexed citations

Vitry, Agnès, et al.. (2023). Traumatologie de la personne sportive de plus de 60 ans : revue systématique. Journal de Traumatologie du Sport. 41(1). 36–45.

Buckley, Elizabeth, et al.. (2023). Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer. Frontiers in Public Health. 11. 1101771–1101771. 3 indexed citations

Vitry, Agnès & Barbara Mintzes. (2021). “Drugs to avoid” to improve quality use of medicines: how is Australia faring?. Journal of Pharmaceutical Policy and Practice. 14(1). 60–60. 2 indexed citations

Ng, Huah Shin, Bogda Koczwara, David Roder, Raymond J. Chan, & Agnès Vitry. (2019). Patterns of health service utilisation among the Australian population with cancer compared with the general population. Australian Health Review. 44(3). 470–479. 8 indexed citations

Ng, Huah Shin, et al.. (2018). Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study (supplementary file). 8(1). 6 indexed citations

10.

Ng, Huah Shin, David Roder, & Agnès Vitry. (2016). Prevalence of Comorbidities and Health Status among Current Cancer and Cancer Survivors: An Australian Population-Based Study. Value in Health. 19(7). A884–A885. 1 indexed citations

11.

Vitry, Agnès, Barbara Mintzes, & Wendy Lipworth. (2016). Access to new cancer medicines in Australia: dispelling the myths and informing a public debate. Journal of Pharmaceutical Policy and Practice. 9(1). 13–13. 14 indexed citations

12.

Vitry, Agnès, et al.. (2013). Assessment of the therapeutic value of new medicines marketed in Australia. Journal of Pharmaceutical Policy and Practice. 6(1). 2–2. 18 indexed citations

13.

Vitry, Agnès. (2010). The Imperative of Happiness for Women Living with Breast Cancer. Canadian women's studies. 28(2). 3 indexed citations

14.

Caughey, Gillian E., Elizabeth E. Roughead, Nicole Pratt, et al.. (2010). Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?. Pharmacoepidemiology and Drug Safety. 19(9). 977–982. 57 indexed citations

15.

Caughey, Gillian E., Elizabeth E. Roughead, Sepehr Shakib, et al.. (2010). Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age and Ageing. 39(4). 488–494. 41 indexed citations

16.

Vitry, Agnès, et al.. (2010). Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia. Internal Medicine Journal. 41(2). 162–166. 7 indexed citations

17.

Thomas, R. & Agnès Vitry. (2009). Consumers' perception of generic medicines in community pharmacies in Malaysia.. 2(2). 20–23. 31 indexed citations

18.

Caughey, Gillian E., Emmae Ramsay, Agnès Vitry, et al.. (2009). Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. Journal of Epidemiology & Community Health. 64(12). 1036–1042. 88 indexed citations

19.

Vitry, Agnès, Joel Lexchin, Larry D. Sasich, et al.. (2008). Provision of information on regulatory authorities’ websites. Internal Medicine Journal. 38(7). 559–567. 15 indexed citations

20.

Vitry, Agnès, et al.. (2002). Place de la coloscopie virtuelle dans le dépistage du cancer colorectal. Acta Endoscopica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact